PROK
ProKidney Corp.
NASDAQ: PROK · HEALTHCARE · BIOTECHNOLOGY
$1.82
-0.55% today
Updated 2026-04-29
Market cap
$552.59M
P/E ratio
—
P/S ratio
618.80x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $6
Volume
0.8M
ProKidney Corp. (PROK) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+14.3%
Last 4 quarters
Revenue YoY growth
+196.1%
Most recent quarter
EPS YoY growth
+12.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-7.2%
2026-03-19
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $-0.14 | +7.3% | $2.08 | $1.93 | -7.2% |
| 2025-11-10 | $-0.12 | +17.9% | $2.89 | $2.80 | -3.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.15 | $-0.14 | +7.3% | $225000.00 | +196.1% |
| 2025-09-30 | $-0.15 | $-0.12 | +17.9% | $217000.00 | — |
| 2025-06-30 | $-0.15 | $-0.13 | +13.3% | $221000.00 | — |
| 2025-03-31 | $-0.16 | $-0.13 | +18.8% | $230000.00 | — |
| 2024-12-31 | $-0.15 | $-0.16 | -6.7% | $76000.00 | -98.3% |
| 2024-09-30 | $-0.15 | $-0.14 | +5.4% | — | — |
| 2024-06-30 | $-0.17 | $-0.16 | +5.9% | — | — |
| 2024-03-31 | $-0.18 | $-0.16 | +11.1% | — | — |
| 2023-12-31 | $-0.17 | $-0.09 | +47.1% | $4.49M | — |
| 2023-09-30 | $-0.16 | $-0.18 | -12.5% | — | — |
| 2023-06-30 | $-0.39 | $-0.14 | +64.1% | — | — |
| 2023-03-31 | $-0.39 | $-0.16 | +59.0% | — | — |
Frequently asked questions
Has ProKidney Corp. beaten earnings estimates?
ProKidney Corp. has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +14.3% over the last 4 quarters.
How does PROK stock react to earnings?
PROK stock has moved an average of -5.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is ProKidney Corp.'s revenue growth rate?
ProKidney Corp. reported year-over-year revenue growth of +196.1% in its most recent quarter, with EPS growing +12.5% year-over-year.